Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tucson, Arizona


Purpose:

The primary purpose of the study is to determine the efficacy of oral dronabinol versus standard ondansetron antiemetic therapy in preventing delayed-onset chemotherapy-induced nausea and vomiting (CINV) or retching by measuring the incidence of total response of nausea and vomiting and/or retching following administration of moderate-to-high emetogenic chemotherapeutic agents.


Criteria:

Inclusion Criteria: - Histological evidence of non-CNS malignancy (primary or metastatic disease) and lymphomas which are not involving the bone marrow. - Undergoing single or multiple days of chemotherapy as long as Day 1 chemotherapy includes: 1. a moderate-to-high emetogenic regimen, or 2. oxaliplatin at doses employed for treatment of colon cancer, or 3. the combination of AC [AdriamycinÒ (60 mg/m2) with cyclophosphamide (600 mg/m2)] as to be used for the chemotherapeutic drug regimen involving taxanes in the treatment of breast cancer. Exclusion Criteria: - Chemotherapy agents falling into the low (Level 1), moderate-to-low (Level 2), moderate (Level 3) unless used in combination with a Level 4 chemotherapy agent on Day 1 of the study. - Chemotherapy agents falling into the high (Level 5) classification during study. - Any combination of chemotherapy agents that does not fall into the moderate-to-high (Level 4) classification


NCT ID:

NCT00642512


Primary Contact:

Study Director
Global Clinical Director Solvay
Solvay Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Tucson, Arizona
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.